Controversies and priorities in amyotrophic lateral sclerosis

DeJesus-Hernandez, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011

Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010

Sreedharan, 2008, TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis, Science, 319, 1668, 10.1126/science.1154584

Vance, 2009, Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6, Science, 323, 1208, 10.1126/science.1165942

Deng, 2011, Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia, Nature, 477, 211, 10.1038/nature10353

Rothstein, 2009, Current hypotheses for the underlying biology of amyotrophic lateral sclerosis, Ann Neurol, 65, S3, 10.1002/ana.21543

Rosen, 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59, 10.1038/362059a0

Turner, 2008, Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS, Prog Neurobiol, 85, 94, 10.1016/j.pneurobio.2008.01.001

Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108

Mitchell, 2010, Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)—a 20-year review: can we do better?, Amyotroph Lateral Scler, 11, 537, 10.3109/17482968.2010.495158

Turner, 2003, Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990–2002, J Neurol Neurosurg Psychiatry, 74, 995, 10.1136/jnnp.74.7.995

Chio, 2011, Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study, J Neurol Neurosurg Psychiatry, 82, 740, 10.1136/jnnp.2010.235952

Brooks, 2000, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph Lateral Scler Other Motor Neuron Disord, 1, 293, 10.1080/146608200300079536

Traynor, 2000, Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study, Arch Neurol, 57, 1171, 10.1001/archneur.57.8.1171

Andersen, 2011, Clinical genetics of amyotrophic lateral sclerosis: what do we really know?, Nat Rev Neurol, 7, 603, 10.1038/nrneurol.2011.150

Juneja, 1997, Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase, Neurology, 48, 55, 10.1212/WNL.48.1.55

Baumer, 2010, Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations, Neurology, 75, 611, 10.1212/WNL.0b013e3181ed9cde

Byrne, 2012, Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study, Lancet Neurol, 11, 232, 10.1016/S1474-4422(12)70014-5

Chio, 2012, Extensive genetics of ALS: a population-based study in Italy, Neurology, 79, 1983, 10.1212/WNL.0b013e3182735d36

Mackenzie, 2007, Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations, Ann Neurol, 61, 427, 10.1002/ana.21147

Al-Sarraj, 2011, p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9ORF72 -linked FTLD and MND/ALS, Acta Neuropathol, 122, 691, 10.1007/s00401-011-0911-2

Phukan, 2012, The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study, J Neurol Neurosurg Psychiatry, 83, 102, 10.1136/jnnp-2011-300188

Elamin, 2011, Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia, Neurology, 76, 1263, 10.1212/WNL.0b013e318214359f

Raaphorst, 2011, Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy, J Neurol Neurosurg Psychiatry, 82, 170, 10.1136/jnnp.2009.204446

Grace, 2011, Neuropsychological functioning in PLS: a comparison with ALS, Can J Neurol Sci, 38, 88, 10.1017/S0317167100120803

Gordon, 2006, The natural history of primary lateral sclerosis, Neurology, 66, 647, 10.1212/01.wnl.0000200962.94777.71

Visser, 2008, The history of progressive muscular atrophy: syndrome or disease?, Neurology, 70, 723, 10.1212/01.wnl.0000302187.20239.93

Van den Berg-Vos, 2009, A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes, Arch Neurol, 66, 751, 10.1001/archneurol.2009.91

Pringle, 1992, Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria, Brain, 115, 495, 10.1093/brain/115.2.495

Vucic, 2007, Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 78, 849, 10.1136/jnnp.2006.105056

Iwata, 2011, White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis, Brain, 134, 2643, 10.1093/brain/awr178

Costa, 2012, Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review, Arch Neurol, 10.1001/archneurol.2012.254

Chou, 1993, Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons, Muscle Nerve, 16, 864, 10.1002/mus.880160810

Dadon-Nachum, 2010, The “dying-back” phenomenon of motor neurons in ALS, J Mol Neurosci, 43, 470, 10.1007/s12031-010-9467-1

Eisen, 1992, Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?, Muscle Nerve, 15, 219, 10.1002/mus.880150215

Eisen, 2009, Amyotrophic lateral sclerosis—evolutionary and other perspectives, Muscle Nerve, 40, 297, 10.1002/mus.21404

Sporns, 2011, The human connectome: a complex network, Ann NY Acad Sci, 1224, 109, 10.1111/j.1749-6632.2010.05888.x

Smith, 2009, Correspondence of the brain's functional architecture during activation and rest, Proc Natl Acad Sci USA, 106, 13040, 10.1073/pnas.0905267106

Douaud, 2011, Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis, Brain, 134, 3470, 10.1093/brain/awr279

Verstraete, 2011, Impaired structural motor connectome in amyotrophic lateral sclerosis, PLoS One, 6, e24239, 10.1371/journal.pone.0024239

Majounie, 2012, Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study, Lancet Neurol, 11, 323, 10.1016/S1474-4422(12)70043-1

Byrne, 2012, Absence of consensus in diagnostic criteria for familial neurodegenerative diseases, J Neurol Neurosurg Psychiatry, 83, 365, 10.1136/jnnp-2011-301530

Hanby, 2011, The risk to relatives of patients with sporadic amyotrophic lateral sclerosis, Brain, 134, 3454, 10.1093/brain/awr248

Talbot, 2011, Familial versus sporadic amyotrophic lateral sclerosis—a false dichotomy?, Brain, 134, 3429, 10.1093/brain/awr296

van Blitterswijk, 2012, Genetic overlap between apparently sporadic motor neuron diseases, PLoS One, 7, e48983, 10.1371/journal.pone.0048983

Hosler, 2000, Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22, JAMA, 284, 1664, 10.1001/jama.284.13.1664

Schymick, 2007, Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data, Lancet Neurol, 6, 322, 10.1016/S1474-4422(07)70037-6

van Es, 2007, ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study, Lancet Neurol, 6, 869, 10.1016/S1474-4422(07)70222-3

Cronin, 2008, A genome-wide association study of sporadic ALS in a homogenous Irish population, Hum Mol Genet, 17, 768, 10.1093/hmg/ddm361

van Es, 2008, Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis, Nat Genet, 40, 29, 10.1038/ng.2007.52

Simpson, 2009, Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration, Hum Mol Genet, 18, 472, 10.1093/hmg/ddn375

Chiò, 2009, A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis, Hum Mol Genet, 18, 1524, 10.1093/hmg/ddp059

Landers, 2009, Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis, Proc Natl Acad Sci USA, 106, 9004, 10.1073/pnas.0812937106

van Es, 2009, Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis, Nat Genet, 41, 1083, 10.1038/ng.442

Li, 2009, Association between DPP6 polymorphism and the risk of sporadic amyotrophic lateral sclerosis in Chinese patients, Chin Med J (Engl), 122, 2989

Shatunov, 2010, Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study, Lancet Neurol, 9, 986, 10.1016/S1474-4422(10)70197-6

Laaksovirta, 2010, Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study, Lancet Neurol, 9, 978, 10.1016/S1474-4422(10)70184-8

Iida, 2011, A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese, Hum Mol Genet, 20, 3684, 10.1093/hmg/ddr268

Kwee, 2012, A high-density genome-wide association screen of sporadic ALS in US veterans, PLoS One, 7, e32768, 10.1371/journal.pone.0032768

2013, Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1, Neurobiol Aging, 34, 357.e7, 10.1016/j.neurobiolaging.2012.07.017

Schymick, 2007, Genetics of sporadic amyotrophic lateral sclerosis, Hum Mol Genet, 16, R233, 10.1093/hmg/ddm215

Scarmeas, 2002, Premorbid weight, body mass, and varsity athletics in ALS, Neurology, 59, 773, 10.1212/WNL.59.5.773

Veldink, 2005, Physical activity and the association with sporadic ALS, Neurology, 64, 241, 10.1212/01.WNL.0000149513.82332.5C

Turner, 2012, Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study, J Neurol Neurosurg Psychiatry, 83, 395, 10.1136/jnnp-2011-301161

Sutedja, 2011, Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 82, 638, 10.1136/jnnp.2010.236752

Huisman, 2011, Family history of neurodegenerative and vascular diseases in ALS: a population-based study, Neurology, 77, 1363, 10.1212/WNL.0b013e318231530b

Chio, 2005, Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players, Brain, 128, 472, 10.1093/brain/awh373

Weisskopf, 2005, Prospective study of military service and mortality from ALS, Neurology, 64, 32, 10.1212/01.WNL.0000148649.17706.D9

Cheah, 2010, Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis, IDrugs, 13, 911

Kiernan, 2009, Amyotrophic lateral sclerosis and the neuroprotective potential of exercise, J Physiol, 597, 3759, 10.1113/jphysiol.2009.177022

de Almeida, 2012, Exercise and amyotrophic lateral sclerosis, Neurol Sci, 33, 9, 10.1007/s10072-011-0921-9

Seeley, 2009, Neurodegenerative diseases target large-scale human brain networks, Neuron, 62, 42, 10.1016/j.neuron.2009.03.024

Bak, 2012, What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease, Cortex, 48, 936, 10.1016/j.cortex.2011.07.008

Turner, 2010, Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 82, 853, 10.1136/jnnp.2010.208413

Turner, 2012, Reduced cancer incidence in Huntington's disease: record linkage study clue to an evolutionary trade-off?, Clinical Genet

Aggarwal, 2002, Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation, J Neurol Neurosurg Psychiatry, 73, 199, 10.1136/jnnp.73.2.199

Vucic, 2008, Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis, Brain, 131, 1540, 10.1093/brain/awn071

Carew, 2011, Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS, Neurology, 77, 1370, 10.1212/WNL.0b013e318231526a

Vivekananda, 2011, Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability, J Neurol Neurosurg Psychiatry, 82, 635

Benatar, 2012, Presymptomatic studies in ALS: rationale, challenges, and approach, Neurology, 79, 1732, 10.1212/WNL.0b013e31826e9b1d

Wohlfart, 1957, Collateral regeneration from residual motor nerve fibers in amyotrophic lateral sclerosis, Neurology, 7, 124, 10.1212/WNL.7.2.124

Ravits, 2009, ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration, Neurology, 73, 805, 10.1212/WNL.0b013e3181b6bbbd

Shoesmith, 2007, Prognosis of amyotrophic lateral sclerosis with respiratory onset, J Neurol Neurosurg Psychiatry, 78, 629, 10.1136/jnnp.2006.103564

Logroscino, 2010, Incidence of amyotrophic lateral sclerosis in Europe, J Neurol Neurosurg Psychiatry, 81, 385, 10.1136/jnnp.2009.183525

Turner, 2012, Young-onset amyotrophic lateral sclerosis: historical and other observations, Brain, 135, 2883, 10.1093/brain/aws144

Grinberg, 2011, Brainstem: neglected locus in neurodegenerative diseases, Front Neurol, 2, 42, 10.3389/fneur.2011.00042

Vucic, 2007, Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 78, 1202, 10.1136/jnnp.2006.112078

Bede, 2012, Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality, J Neurol Neurosurg Psychiatry

van den Heuvel, 2011, Rich-club organization of the human connectome, J Neurosci, 31, 15775, 10.1523/JNEUROSCI.3539-11.2011

Verstraete, 2010, Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study, PLoS One, 5, e13664, 10.1371/journal.pone.0013664

Polymenidou, 2011, The seeds of neurodegeneration: prion-like spreading in ALS, Cell, 147, 498, 10.1016/j.cell.2011.10.011

Kanouchi, 2012, Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?, J Neurol Neurosurg Psychiatry, 83, 739, 10.1136/jnnp-2011-301826

Swash, 2013, How does ALS spread between neurones in the CNS?, J Neurol Neurosurg Psychiatry, 84, 116, 10.1136/jnnp-2012-303992

Sabatelli, 2011, Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS, Amyotroph Lateral Scler, 12, 278, 10.3109/17482968.2011.580849

Turner, 2010, Pattern of spread and prognosis in lower limb-onset ALS, Amyotroph Lateral Scler, 11, 369, 10.3109/17482960903420140

Fujimura-Kiyono, 2011, Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 82, 1244, 10.1136/jnnp-2011-300141

Gargiulo-Monachelli, 2012, Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis, Eur J Neurol, 19, 834, 10.1111/j.1468-1331.2011.03616.x

Haverkamp, 1995, Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction, Brain, 118, 707, 10.1093/brain/118.3.707

Turner, 2002, Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis, Amyotroph Lateral Scler Other Motor Neuron Disord, 3, 15, 10.1080/146608202317576499

Roche, 2012, A proposed staging system for amyotrophic lateral sclerosis, Brain, 135, 847, 10.1093/brain/awr351

Burrell, 2011, Isolated bulbar phenotype of amyotrophic lateral sclerosis, Amyotroph Lateral Scler, 12, 283, 10.3109/17482968.2011.551940

Cudkowicz, 2010, Toward more efficient clinical trials for amyotrophic lateral sclerosis, Amyotroph Lateral Scler, 11, 259, 10.3109/17482960903358865

Turner, 2012, Neuroimaging in amyotrophic lateral sclerosis, Biomark Med, 6, 319, 10.2217/bmm.12.26

Turner, 2009, Biomarkers in amyotrophic lateral sclerosis, Lancet Neurol, 8, 94, 10.1016/S1474-4422(08)70293-X

Bowser, 2011, Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations, Nat Rev Neurol, 7, 631, 10.1038/nrneurol.2011.151

Cedarbaum, 1999, The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III), J Neurol Sci, 169, 13, 10.1016/S0022-510X(99)00210-5

Kimura, 2006, Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS, Neurology, 66, 265, 10.1212/01.wnl.0000194316.91908.8a

Gordon, 2010, Progression in ALS is not linear but is curvilinear, J Neurol, 257, 1713, 10.1007/s00415-010-5609-1

Cudkowicz, 2011, The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis, Nat Med, 17, 1652, 10.1038/nm.2579

Swash, 2004, The neurophysiological index in ALS, Amyotroph Lateral Scler Other Motor Neuron Disord, 5, 108, 10.1080/17434470410020067

Cheah, 2011, Neurophysiological index as a biomarker for ALS progression: validity of mixed effects models, Amyotroph Lateral Scler, 12, 33, 10.3109/17482968.2010.531742

Ludolph, 2007, Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop, Amyotroph Lateral Scler, 8, 217, 10.1080/17482960701292837

Ludolph, 2010, Guidelines for preclinical animal research in ALS/MND: a consensus meeting, Amyotroph Lateral Scler, 11, 38, 10.3109/17482960903545334

Benatar, 2007, Lost in translation: treatment trials in the SOD1 mouse and in human ALS, Neurobiol Dis, 26, 1, 10.1016/j.nbd.2006.12.015

Scott, 2008, Design, power, and interpretation of studies in the standard murine model of ALS, Amyotroph Lateral Scler, 9, 4, 10.1080/17482960701856300

Brockington, 2013, Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity, Acta Neuropathol, 125, 95, 10.1007/s00401-012-1058-5

Sawin, 2000, C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway, Neuron, 26, 219, 10.1016/S0896-6273(00)81199-X

Kraemer, 2003, Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy, Proc Natl Acad Sci USA, 100, 9980, 10.1073/pnas.1533448100

Miyasaka, 2005, Progressive neurodegeneration in C. elegans model of tauopathy, Neurobiol Dis, 20, 372, 10.1016/j.nbd.2005.03.017

Thomson, 2012, Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality?, J Anat, 220, 122, 10.1111/j.1469-7580.2011.01459.x

Bilican, 2012, Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability, Proc Natl Acad Sci USA, 109, 5803, 10.1073/pnas.1202922109

Tashiro, 2012, Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis, J Biol Chem, 287, 42984, 10.1074/jbc.M112.417600

Kiernan, 2011, Amyotrophic lateral sclerosis, Lancet, 377, 942, 10.1016/S0140-6736(10)61156-7